These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13668045)

  • 41. Toxicity and effects of increasing doses of mescaline.
    SPECK LB
    J Pharmacol Exp Ther; 1957 Jan; 119(1):78-84. PubMed ID: 13417062
    [No Abstract]   [Full Text] [Related]  

  • 42. [Injurious effects of mescaline].
    TEIRICH H
    Psyche (Stuttg); 1954 Jan; 7(10):637-40. PubMed ID: 13145711
    [No Abstract]   [Full Text] [Related]  

  • 43. [Some special aspects of alcoholism in women].
    FOLLIN S; PIVET S
    Rev Neurol (Paris); 1956 May; 94(5):646-9. PubMed ID: 13390280
    [No Abstract]   [Full Text] [Related]  

  • 44. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.
    Lewis V; Bonniwell EM; Lanham JK; Ghaffari A; Sheshbaradaran H; Cao AB; Calkins MM; Bautista-Carro MA; Arsenault E; Telfer A; Taghavi-Abkuh FF; Malcolm NJ; El Sayegh F; Abizaid A; Schmid Y; Morton K; Halberstadt AL; Aguilar-Valles A; McCorvy JD
    Cell Rep; 2023 Mar; 42(3):112203. PubMed ID: 36884348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
    Johnson MW
    Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new adjunct to the treatment of alcoholism: the hallucinogenic drugs.
    SMITH CM
    Q J Stud Alcohol; 1958 Sep; 19(3):406-17. PubMed ID: 13579169
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mescaline and psychotherapy].
    Turns D; Denber HC
    Arzneimittelforschung; 1966 Feb; 16(2):251-3. PubMed ID: 6013809
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacological studies on hallucinogens. I. Investigation of the action of mescaline on the central nervous system, with special reference to its effect on mental function].
    HOSHIKAWA E
    Nihon Yakurigaku Zasshi; 1962 May; 58():241-60. PubMed ID: 14449160
    [No Abstract]   [Full Text] [Related]  

  • 49. Finding medical value in mescaline.
    Bender E
    Nature; 2022 Sep; 609(7929):S90-S91. PubMed ID: 36171368
    [No Abstract]   [Full Text] [Related]  

  • 50. Some reflections on the possible therapeutic effects of the hallucinogens; with special reference to alcoholism.
    SMITH CM
    Q J Stud Alcohol; 1959 Jun; 20(2):292-301. PubMed ID: 13668045
    [No Abstract]   [Full Text] [Related]  

  • 51. [Mental and behavioral disturbances caused by psychotropic agents: with special reference to alcohol dependence].
    Saito T
    Seishin Shinkeigaku Zasshi; 2008; 110(3):250-5. PubMed ID: 18524052
    [No Abstract]   [Full Text] [Related]  

  • 52. Hallucinogens.
    Nichols DE
    Pharmacol Ther; 2004 Feb; 101(2):131-81. PubMed ID: 14761703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Alcoholism treatments].
    Jacques D
    J Pharm Belg; 2006; 61(1):30-6. PubMed ID: 16669345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural medicines for alcoholism treatment: a review.
    Xu BJ; Zheng YN; Sung CK
    Drug Alcohol Rev; 2005 Nov; 24(6):525-36. PubMed ID: 16361209
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.